arrow
C

Ciarán Gilbride

University of Oxford
H指数:17
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity and protective efficacy of single-dose adenoviral vaccines expressing Crimean-Congo haemorrhagic fever virus GP38, Gc, or nucleoprotein antigens in mice: a preclinical study

单剂量表达克里米亚-刚果出血热病毒GP38、Gc或核蛋白抗原的腺病毒疫苗的免疫原性和保护效力研究:一项临床前研究

2026-10-210
OA
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion

SARS-CoV-2亚基因组RNA的出现,增强了病毒适应性和免疫逃逸能力

2025-01-211
OA
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials

两剂ChAdOx1 nCov-19 (AZD1222) 后免疫反应的持续性: 两项随机对照试验的1年随访

2023-02-028
OAAI
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
2021-07-2615
OAAI
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

自我扩增RNA和腺病毒COVID疫苗的异源疫苗接种方案在小鼠中诱导强大的免疫反应

2021-05-1795
OAAI
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (vol 27, pg 279, 2021)
2021-05-066
OAAI
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
2020-12-17233
OAAI
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
2020-07-27104
OAAI